Atlas Trials

Optimizing HBV Management During Anti-CD20 Antibodies

Clinical trial NCT03155984 · COMPLETED

Trial details

NCT number
NCT03155984
Sponsor
The University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
Liver DysfunctionImmune SuppressionHepatitis B
Start date
2013-10-01
Primary completion
2017-06-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.